Some fusion companies might be hitting a rough patch, but Realta Fusion is bucking the trend with a new fundraising round it says will allow it to finalize the design of its Anvil prototype reactor.

The MarketWatch News Department was not involved in the creation of this content. David Marek, a current ReAlta Board member and accomplished executive who, as CEO of Myovant Sciences, led the ...

Poster Presentation: "Early Granulocyte Inflammatory Biomarkers in Newborn Babies with Moderate or Severe Hypoxic Ischemic Encephalopathy" Biomarker data from the ongoing Phase 2 STAR trial provide ...

Subscribe to BizTimes Daily – Local news about the people, companies and issues that impact business in Milwaukee and Southeast Wisconsin. Green Bay-based venture capital firm TitletownTech has made ...

ReAlta Life Sciences, Inc. (“ReAlta” or the “Company”), a clinical-stage biopharmaceutical company dedicated to saving lives by rebalancing the inflammatory response to address rare and acute ...

NORFOLK, Va .--(BUSINESS WIRE)--ReAlta Life Sciences, Inc. (“ReAlta” or the “Company”), a clinical mid-stage biotech company focused on harnessing the power of the immune system to address ...

CoastalOne, an independent broker-dealer and RIA platform for advisors and firms that focus on affluent and high-net-worth investors, has rebranded as Realta Wealth, the firm announced today. The name ...

NORFOLK, Va.--(BUSINESS WIRE)--ReAlta Life Sciences, Inc. ("ReAlta" or the “Company”), a clinical-stage biopharmaceutical company dedicated to saving lives by rebalancing the inflammatory response to ...